GO:0003678 | DNA helicase activity | 2.36e-06 | 2.30e-02 | 6.762 | 3 | 3 | 18 |
GO:0016363 | nuclear matrix | 3.69e-06 | 3.60e-02 | 5.157 | 4 | 7 | 73 |
GO:0005654 | nucleoplasm | 1.48e-05 | 1.44e-01 | 2.572 | 8 | 55 | 876 |
GO:0005730 | nucleolus | 1.75e-05 | 1.70e-01 | 2.267 | 9 | 41 | 1217 |
GO:0032508 | DNA duplex unwinding | 2.40e-05 | 2.34e-01 | 5.684 | 3 | 5 | 38 |
GO:0000812 | Swr1 complex | 4.60e-05 | 4.50e-01 | 7.539 | 2 | 2 | 7 |
GO:0031011 | Ino80 complex | 6.13e-05 | 5.99e-01 | 7.347 | 2 | 2 | 8 |
GO:0043968 | histone H2A acetylation | 9.84e-05 | 9.61e-01 | 7.025 | 2 | 2 | 10 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.44e-04 | 1.00e+00 | 6.762 | 2 | 3 | 12 |
GO:0016020 | membrane | 1.53e-04 | 1.00e+00 | 2.109 | 8 | 38 | 1207 |
GO:0070062 | extracellular vesicular exosome | 1.98e-04 | 1.00e+00 | 1.836 | 9 | 43 | 1641 |
GO:0005839 | proteasome core complex | 2.61e-04 | 1.00e+00 | 6.347 | 2 | 9 | 16 |
GO:0005634 | nucleus | 2.74e-04 | 1.00e+00 | 1.267 | 12 | 67 | 3246 |
GO:0004298 | threonine-type endopeptidase activity | 2.96e-04 | 1.00e+00 | 6.259 | 2 | 9 | 17 |
GO:0071339 | MLL1 complex | 3.32e-04 | 1.00e+00 | 6.177 | 2 | 2 | 18 |
GO:0043967 | histone H4 acetylation | 5.00e-04 | 1.00e+00 | 5.887 | 2 | 2 | 22 |
GO:0000082 | G1/S transition of mitotic cell cycle | 8.33e-04 | 1.00e+00 | 3.966 | 3 | 24 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 8.92e-04 | 1.00e+00 | 3.931 | 3 | 8 | 128 |
GO:0010467 | gene expression | 9.19e-04 | 1.00e+00 | 2.605 | 5 | 31 | 535 |
GO:0015030 | Cajal body | 1.06e-03 | 1.00e+00 | 5.347 | 2 | 2 | 32 |
GO:0000278 | mitotic cell cycle | 1.08e-03 | 1.00e+00 | 3.052 | 4 | 35 | 314 |
GO:0040008 | regulation of growth | 1.42e-03 | 1.00e+00 | 5.137 | 2 | 2 | 37 |
GO:1990259 | histone-glutamine methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.74e-03 | 1.00e+00 | 4.989 | 2 | 16 | 41 |
GO:0008380 | RNA splicing | 1.86e-03 | 1.00e+00 | 3.565 | 3 | 7 | 165 |
GO:0000502 | proteasome complex | 2.29e-03 | 1.00e+00 | 4.792 | 2 | 17 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.48e-03 | 1.00e+00 | 4.732 | 2 | 3 | 49 |
GO:0006310 | DNA recombination | 2.59e-03 | 1.00e+00 | 4.703 | 2 | 6 | 50 |
GO:0006334 | nucleosome assembly | 2.69e-03 | 1.00e+00 | 4.674 | 2 | 4 | 51 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.79e-03 | 1.00e+00 | 4.646 | 2 | 17 | 52 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.90e-03 | 1.00e+00 | 4.619 | 2 | 17 | 53 |
GO:0030953 | astral microtubule organization | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0005681 | spliceosomal complex | 3.12e-03 | 1.00e+00 | 4.565 | 2 | 2 | 55 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.23e-03 | 1.00e+00 | 4.539 | 2 | 17 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.35e-03 | 1.00e+00 | 4.514 | 2 | 16 | 57 |
GO:0006281 | DNA repair | 3.35e-03 | 1.00e+00 | 3.266 | 3 | 19 | 203 |
GO:0043234 | protein complex | 3.69e-03 | 1.00e+00 | 3.217 | 3 | 8 | 210 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.70e-03 | 1.00e+00 | 4.440 | 2 | 17 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 3.83e-03 | 1.00e+00 | 4.416 | 2 | 5 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.83e-03 | 1.00e+00 | 4.416 | 2 | 16 | 61 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.33e-03 | 1.00e+00 | 4.324 | 2 | 17 | 65 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0001652 | granular component | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0031428 | box C/D snoRNP complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0006325 | chromatin organization | 5.01e-03 | 1.00e+00 | 4.217 | 2 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 5.01e-03 | 1.00e+00 | 4.217 | 2 | 16 | 70 |
GO:0001649 | osteoblast differentiation | 5.58e-03 | 1.00e+00 | 4.137 | 2 | 2 | 74 |
GO:0051414 | response to cortisol | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 6.81e-03 | 1.00e+00 | 3.989 | 2 | 4 | 82 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0014075 | response to amine | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0000209 | protein polyubiquitination | 8.51e-03 | 1.00e+00 | 3.823 | 2 | 16 | 92 |
GO:0001055 | RNA polymerase II activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0042555 | MCM complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0022027 | interkinetic nuclear migration | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0016887 | ATPase activity | 1.00e-02 | 1.00e+00 | 3.703 | 2 | 6 | 100 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0070063 | RNA polymerase binding | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.10e-02 | 1.00e+00 | 3.632 | 2 | 18 | 105 |
GO:0004198 | calcium-dependent cysteine-type endopeptidase activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0031122 | cytoplasmic microtubule organization | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 8 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0042981 | regulation of apoptotic process | 1.24e-02 | 1.00e+00 | 3.539 | 2 | 18 | 112 |
GO:0032886 | regulation of microtubule-based process | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0021591 | ventricular system development | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0008266 | poly(U) RNA binding | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0003924 | GTPase activity | 1.39e-02 | 1.00e+00 | 3.452 | 2 | 3 | 119 |
GO:0005515 | protein binding | 1.49e-02 | 1.00e+00 | 0.796 | 11 | 76 | 4124 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 10 |
GO:0042802 | identical protein binding | 1.55e-02 | 1.00e+00 | 2.464 | 3 | 7 | 354 |
GO:0006184 | GTP catabolic process | 1.65e-02 | 1.00e+00 | 3.324 | 2 | 3 | 130 |
GO:0007020 | microtubule nucleation | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 11 |
GO:0046827 | positive regulation of protein export from nucleus | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 11 |
GO:0071392 | cellular response to estradiol stimulus | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0060749 | mammary gland alveolus development | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0010243 | response to organonitrogen compound | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0005719 | nuclear euchromatin | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0022008 | neurogenesis | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0016032 | viral process | 2.57e-02 | 1.00e+00 | 2.190 | 3 | 32 | 428 |
GO:0006206 | pyrimidine nucleobase metabolic process | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 17 |
GO:0001944 | vasculature development | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 17 |
GO:0006270 | DNA replication initiation | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 4 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 18 |
GO:0016071 | mRNA metabolic process | 2.73e-02 | 1.00e+00 | 2.937 | 2 | 21 | 170 |
GO:0033574 | response to testosterone | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 18 |
GO:0000794 | condensed nuclear chromosome | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0045596 | negative regulation of cell differentiation | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 20 |
GO:0017144 | drug metabolic process | 3.18e-02 | 1.00e+00 | 4.954 | 1 | 1 | 21 |
GO:0016070 | RNA metabolic process | 3.28e-02 | 1.00e+00 | 2.792 | 2 | 21 | 188 |
GO:0030331 | estrogen receptor binding | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 22 |
GO:0005525 | GTP binding | 3.58e-02 | 1.00e+00 | 2.724 | 2 | 5 | 197 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 24 |
GO:0048839 | inner ear development | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 25 |
GO:0008033 | tRNA processing | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 1 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 27 |
GO:0005829 | cytosol | 4.15e-02 | 1.00e+00 | 1.128 | 6 | 58 | 1787 |
GO:0005524 | ATP binding | 4.17e-02 | 1.00e+00 | 1.546 | 4 | 23 | 892 |
GO:0034644 | cellular response to UV | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 28 |
GO:0005813 | centrosome | 4.27e-02 | 1.00e+00 | 2.585 | 2 | 8 | 217 |
GO:0006271 | DNA strand elongation involved in DNA replication | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 8 | 29 |
GO:0018107 | peptidyl-threonine phosphorylation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 2 | 29 |
GO:0021987 | cerebral cortex development | 4.51e-02 | 1.00e+00 | 4.440 | 1 | 2 | 30 |
GO:0043195 | terminal bouton | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 1 | 31 |
GO:0007595 | lactation | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 2 | 32 |
GO:0014070 | response to organic cyclic compound | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 2 | 35 |
GO:0000226 | microtubule cytoskeleton organization | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 36 |
GO:0003723 | RNA binding | 5.39e-02 | 1.00e+00 | 2.398 | 2 | 11 | 247 |
GO:0035690 | cellular response to drug | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 2 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 6 | 40 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 2 | 40 |
GO:0042995 | cell projection | 6.12e-02 | 1.00e+00 | 3.989 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 6.12e-02 | 1.00e+00 | 3.989 | 1 | 9 | 41 |
GO:0031100 | organ regeneration | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 44 |
GO:0060021 | palate development | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 5 | 48 |
GO:0030097 | hemopoiesis | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 48 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 9 | 53 |
GO:0042393 | histone binding | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 3 | 54 |
GO:0005737 | cytoplasm | 8.10e-02 | 1.00e+00 | 0.791 | 7 | 50 | 2633 |
GO:0006338 | chromatin remodeling | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 2 | 55 |
GO:0043066 | negative regulation of apoptotic process | 8.58e-02 | 1.00e+00 | 2.016 | 2 | 20 | 322 |
GO:0007565 | female pregnancy | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 2 | 64 |
GO:0006364 | rRNA processing | 9.82e-02 | 1.00e+00 | 3.280 | 1 | 4 | 67 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 9.82e-02 | 1.00e+00 | 3.280 | 1 | 2 | 67 |
GO:0005200 | structural constituent of cytoskeleton | 9.96e-02 | 1.00e+00 | 3.259 | 1 | 2 | 68 |
GO:0051082 | unfolded protein binding | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 4 | 70 |
GO:0001889 | liver development | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 1 | 71 |
GO:0051726 | regulation of cell cycle | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 2 | 73 |
GO:0005815 | microtubule organizing center | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 1 | 77 |
GO:0044822 | poly(A) RNA binding | 1.19e-01 | 1.00e+00 | 1.289 | 3 | 25 | 799 |
GO:0006915 | apoptotic process | 1.29e-01 | 1.00e+00 | 1.664 | 2 | 21 | 411 |
GO:0044281 | small molecule metabolic process | 1.34e-01 | 1.00e+00 | 1.210 | 3 | 32 | 844 |
GO:0006260 | DNA replication | 1.35e-01 | 1.00e+00 | 2.792 | 1 | 11 | 94 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 5 | 97 |
GO:0006457 | protein folding | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 4 | 97 |
GO:0007507 | heart development | 1.51e-01 | 1.00e+00 | 2.619 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 1.51e-01 | 1.00e+00 | 2.619 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 1.55e-01 | 1.00e+00 | 2.578 | 1 | 3 | 109 |
GO:0006397 | mRNA processing | 1.56e-01 | 1.00e+00 | 2.565 | 1 | 2 | 110 |
GO:0001666 | response to hypoxia | 1.64e-01 | 1.00e+00 | 2.489 | 1 | 1 | 116 |
GO:0016607 | nuclear speck | 1.72e-01 | 1.00e+00 | 2.416 | 1 | 3 | 122 |
GO:0004672 | protein kinase activity | 1.76e-01 | 1.00e+00 | 2.381 | 1 | 2 | 125 |
GO:0019904 | protein domain specific binding | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 2 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.97e-01 | 1.00e+00 | 2.197 | 1 | 2 | 142 |
GO:0005622 | intracellular | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 1 | 145 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.21e-01 | 1.00e+00 | 2.016 | 1 | 4 | 161 |
GO:0006351 | transcription, DNA-templated | 2.24e-01 | 1.00e+00 | 0.860 | 3 | 9 | 1076 |
GO:0007067 | mitotic nuclear division | 2.26e-01 | 1.00e+00 | 1.980 | 1 | 8 | 165 |
GO:0007283 | spermatogenesis | 2.29e-01 | 1.00e+00 | 1.954 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 2.33e-01 | 1.00e+00 | 1.929 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 2.39e-01 | 1.00e+00 | 1.887 | 1 | 6 | 176 |
GO:0005743 | mitochondrial inner membrane | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 3 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.70e-01 | 1.00e+00 | 1.681 | 1 | 1 | 203 |
GO:0019899 | enzyme binding | 2.78e-01 | 1.00e+00 | 1.632 | 1 | 4 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 2.87e-01 | 1.00e+00 | 1.578 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 2.89e-01 | 1.00e+00 | 1.572 | 1 | 8 | 219 |
GO:0006508 | proteolysis | 3.37e-01 | 1.00e+00 | 1.302 | 1 | 3 | 264 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.91e-01 | 1.00e+00 | 1.038 | 1 | 7 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 4.13e-01 | 1.00e+00 | 0.933 | 1 | 6 | 341 |
GO:0005509 | calcium ion binding | 4.23e-01 | 1.00e+00 | 0.891 | 1 | 3 | 351 |
GO:0003677 | DNA binding | 4.35e-01 | 1.00e+00 | 0.459 | 2 | 18 | 947 |
GO:0005794 | Golgi apparatus | 4.79e-01 | 1.00e+00 | 0.650 | 1 | 5 | 415 |
GO:0045087 | innate immune response | 5.09e-01 | 1.00e+00 | 0.526 | 1 | 7 | 452 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.41e-01 | 1.00e+00 | 0.016 | 1 | 8 | 644 |
GO:0005739 | mitochondrion | 6.50e-01 | 1.00e+00 | -0.018 | 1 | 11 | 659 |
GO:0008270 | zinc ion binding | 6.87e-01 | 1.00e+00 | -0.159 | 1 | 7 | 727 |
GO:0005886 | plasma membrane | 9.52e-01 | 1.00e+00 | -1.454 | 1 | 11 | 1784 |